TY - JOUR
T1 - Monocyte-derived macrophages aggravate pulmonary vasculitis via cGAS/STING/IFN-mediated nucleic acid sensing
AU - Kessler, Nina
AU - Viehmann, Susanne F.
AU - Krollmann, Calvin
AU - Mai, Karola
AU - Kirschner, Katharina M.
AU - Luksch, Hella
AU - Kotagiri, Prasanti
AU - Böhner, Alexander M.C.
AU - Huugen, Dennis
AU - de Oliveira Mann, Carina C.
AU - Otten, Simon
AU - Weiss, Stefanie A.I.
AU - Zillinger, Thomas
AU - Dobrikova, Kristiyana
AU - Jenne, Dieter E.
AU - Behrendt, Rayk
AU - Ablasser, Andrea
AU - Bartok, Eva
AU - Hartmann, Gunther
AU - Hopfner, Karl Peter
AU - Lyons, Paul A.
AU - Boor, Peter
AU - Rösen-Wolff, Angela
AU - Teichmann, Lino L.
AU - Heeringa, Peter
AU - Kurts, Christian
AU - Garbi, Natalio
N1 - Publisher Copyright:
© 2022 Kessler et al.
PY - 2022/10/3
Y1 - 2022/10/3
N2 - Autoimmune vasculitis is a group of life-threatening diseases, whose underlying pathogenic mechanisms are incompletely understood, hampering development of targeted therapies. Here, we demonstrate that patients suffering from anti-neutrophil cytoplasmic antibodies (ANCA)–associated vasculitis (AAV) showed increased levels of cGAMP and enhanced IFN-I signature. To identify disease mechanisms and potential therapeutic targets, we developed a mouse model for pulmonary AAV that mimics severe disease in patients. Immunogenic DNA accumulated during disease onset, triggering cGAS/STING/IRF3-dependent IFN-I release that promoted endothelial damage, pulmonary hemorrhages, and lung dysfunction. Macrophage subsets played dichotomic roles in disease. While recruited monocyte-derived macrophages were major disease drivers by producing most IFN-β, resident alveolar macrophages contributed to tissue homeostasis by clearing red blood cells and limiting infiltration of IFN-β–producing macrophages. Moreover, pharmacological inhibition of STING, IFNAR-I, or its downstream JAK/STAT signaling reduced disease severity and accelerated recovery. Our study unveils the importance of STING/IFN-I axis in promoting pulmonary AAV progression and identifies cellular and molecular targets to ameliorate disease outcomes.
AB - Autoimmune vasculitis is a group of life-threatening diseases, whose underlying pathogenic mechanisms are incompletely understood, hampering development of targeted therapies. Here, we demonstrate that patients suffering from anti-neutrophil cytoplasmic antibodies (ANCA)–associated vasculitis (AAV) showed increased levels of cGAMP and enhanced IFN-I signature. To identify disease mechanisms and potential therapeutic targets, we developed a mouse model for pulmonary AAV that mimics severe disease in patients. Immunogenic DNA accumulated during disease onset, triggering cGAS/STING/IRF3-dependent IFN-I release that promoted endothelial damage, pulmonary hemorrhages, and lung dysfunction. Macrophage subsets played dichotomic roles in disease. While recruited monocyte-derived macrophages were major disease drivers by producing most IFN-β, resident alveolar macrophages contributed to tissue homeostasis by clearing red blood cells and limiting infiltration of IFN-β–producing macrophages. Moreover, pharmacological inhibition of STING, IFNAR-I, or its downstream JAK/STAT signaling reduced disease severity and accelerated recovery. Our study unveils the importance of STING/IFN-I axis in promoting pulmonary AAV progression and identifies cellular and molecular targets to ameliorate disease outcomes.
UR - http://www.scopus.com/inward/record.url?scp=85137123988&partnerID=8YFLogxK
U2 - 10.1084/jem.20220759
DO - 10.1084/jem.20220759
M3 - Article
C2 - 35997679
AN - SCOPUS:85137123988
SN - 0022-1007
VL - 219
JO - Journal of Experimental Medicine
JF - Journal of Experimental Medicine
IS - 10
M1 - e20220759
ER -